Mortality or serious adverse events requiring hospital admission · Adults or children at increased risk of bacterial endocarditis (pre-existing cardiac condition) undergoing an invasive dental procedure
The review found no eligible studies for this question.
1 finding from 1 review
Development of endocarditis due to other (non-dental) causes · Adults or children at increased risk of bacterial endocarditis (pre-existing cardiac condition) undergoing an invasive dental procedure
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
Necrotising enterocolitis prior to hospital discharge · very preterm (< 32 weeks' gestation) or very low birth weight (< 1500 g) infants
The intervention may leads to lower necrotising enterocolitis prior to hospital discharge (low certainty).
1 finding from 1 review
Intervention not reported
Mortality prior to hospital discharge · very preterm (< 32 weeks' gestation) or very low birth weight (< 1500 g) infants
The intervention showed no clear difference in mortality prior to hospital discharge (low certainty).
1 finding from 1 review
Intervention not reported
Feed intolerance prior to hospital discharge · very preterm (< 32 weeks' gestation) or very low birth weight (< 1500 g) infants
The intervention may leads to lower feed intolerance prior to hospital discharge (low certainty).
1 finding from 1 review
Intervention not reported
Invasive infection prior to hospital discharge · very preterm (< 32 weeks' gestation) or very low birth weight (< 1500 g) infants
The intervention probably leads to higher invasive infection prior to hospital discharge (moderate certainty).
1 finding from 1 review
Combined outcome of mortality or BPD at 36 weeks' PMA · preterm infants
It is very uncertain whether inhaled corticosteroids changes combined outcome of mortality or BPD at 36 weeks' PMA compared with placebo (very low certainty).
1 finding from 1 review
Mortality at 36 weeks' PMA · preterm infants
It is very uncertain whether inhaled corticosteroids changes mortality at 36 weeks' PMA compared with placebo (very low certainty).
1 finding from 1 review
Bronchopulmonary dysplasia/chronic lung disease · preterm infants
It is very uncertain whether inhaled corticosteroids changes BPD at 36 weeks' PMA compared with placebo (very low certainty).
1 finding from 1 review
Open‐label use of systemic corticosteroids · preterm infants
It is very uncertain whether inhaled corticosteroids changes open‐label use of systemic corticosteroids compared with placebo (very low certainty).
1 finding from 1 review
Interventions versus comparisons
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Duration of bleeding
1 finding from 1 review
Side effects: gastrointestinal disturbances (diarrhoea, lower abdominal pain), headache and sweating
It is very uncertain whether interventions (vitamin B1, mefenamic acid, tranexamic acid) changes side effects: gastrointestinal disturbances (diarrhoea, lower… compared with placebo or active comparators (desmopressin, sodium diclofenac,… (very low certainty).
1 finding from 1 review
Menstrual blood loss PBAC score
2 findings from 1 review
Menstrual blood loss Number of pads (diary record)
2 findings from 1 review
Duration of bleeding Number of bleeding days
2 findings from 1 review
Adverse effects: headache
Interventions (vitamin B1, mefenamic acid, tranexamic acid) showed no clear difference in side effects: headache compared with placebo or active comparators (desmopressin, sodium diclofenac,… (low certainty).
1 finding from 1 review
Vomiting
Interventions (vitamin B1, mefenamic acid, tranexamic acid) showed no clear difference in side effects: vomiting compared with placebo or active comparators (desmopressin, sodium diclofenac,… (low certainty).
1 finding from 1 review
Vitamin B1 vs placebo
1 finding from 1 review
no estimate extracted
1 participants
GRADE not reported
Duration of bleeding (menstrual diary)
2 findings from 1 review